7.4 Delivery of Drugs: Will-Call, Agent Pickup, Courier & Mail
Key Takeaways
- Delivery does not end the pharmacist's duties: the counseling obligation under N.J.A.C. 13:39-7.21 and the DUR obligation under 13:39-7.20 attach to the dispensing, not to the handover, so mailed and delivered prescriptions require an alternative counseling mechanism.
- Pharmacies that deliver or mail must provide written drug information and maintain a toll-free telephone consultation service staffed by a pharmacist at least 6 days and 40 hours per week, with the number appearing on the prescription label.
- An out-of-State pharmacy that ships prescriptions into New Jersey must be registered with the Board under N.J.A.C. 13:39-4.20 and must maintain a valid, unexpired license in its home jurisdiction at all times.
- A central fill pharmacy may not deliver dispensed medication directly to a patient unless it is separately licensed by the Board as a retail pharmacy, and the label must identify the originating pharmacy.
- Delivery to an agent of the patient is permitted, but the pharmacy must be able to reconstruct the transaction — who received the medication and when — through its records and audit trail.
7.4 Delivery of Drugs: Will-Call, Agent Pickup, Courier & Mail
[!NOTE] Core Legal Authorities: Patient counseling (N.J.A.C. 13:39-7.21), drug utilization review (N.J.A.C. 13:39-7.20), labeling (N.J.A.C. 13:39-7.12), return of prescription medication and the abandonment definition (N.J.A.C. 13:39-7.16), required records and the audit trail (N.J.A.C. 13:39-7.6), out-of-State pharmacy registration (N.J.A.C. 13:39-4.20), centralized prescription handling (N.J.A.C. 13:39-4.18), and the federal controlled substance delivery framework at 21 CFR Part 1306.
"Delivery of drugs" is a standalone competency in Area 4 of the MPJE blueprint, and it is easy to under-prepare because nothing dramatic happens at the handover. That is exactly the point the exam tests: the professional obligations attach to the dispensing, not to the transfer, so every duty that would apply across the counter has to be satisfied some other way when the product is mailed, couriered, or handed to somebody else.
Four Delivery Channels, One Set of Duties
Dispensed prescription
│
┌──────────────┬───────────┴───────────┬──────────────┐
▼ ▼ ▼ ▼
Will-call Agent pickup Courier / Mail /
(patient) (family, friend, home delivery common carrier
caregiver, aide)
│ │ │ │
└──────────────┴───────────┬───────────┴──────────────┘
▼
DUR (7.20) + labeling (7.12) + counseling mechanism (7.21)
+ audit trail (7.6) apply in EVERY channel
1. Will-Call
A bagged prescription waiting in the will-call bin has been prepared and made available for dispensing but has not been dispensed. That phrase is not incidental — it is the trigger language of N.J.A.C. 13:39-7.16(c), under which the medication becomes abandoned if it is not dispensed to the intended patient within two weeks. Will-call management is therefore a legal process, not a housekeeping one: bins must be reconciled, patients contacted, and abandoned product either returned to stock under the six conditions of 13:39-7.16(c) or removed.
Will-call storage must also respect the labeling and storage rules that apply to any stock: refrigerated items belong in the refrigerator with a will-call flag, not in the bin, and the pharmacy's temperature logs cover them.
2. Release to an Agent of the Patient
New Jersey pharmacies routinely release prescriptions to a spouse, adult child, neighbor, or home health aide. Two constraints govern:
- Counseling still has to happen. Under 13:39-7.21 the offer to counsel is made on new prescriptions, and the counseling must be delivered by a pharmacist or registered intern — never by a technician or clerk. When an agent collects the medication, the pharmacist should offer counseling to the patient by telephone or provide the means for the patient to obtain it, rather than treating the agent's presence as a waiver.
- The transaction must be reconstructable. The audit trail requirement of 13:39-7.6 and the general records duty mean the pharmacy should be able to show what was released, to whom, and when.
Controlled substances warrant additional identification discipline. A pharmacist releasing a Schedule II analgesic to someone other than the patient should obtain and document suitable identification — the same instinct the Board applied when it directed pharmacists to obtain suitable identification before emergency dispensing under 13:39-7.4.
3. Courier and Home Delivery
Delivery by pharmacy staff or a contracted courier does not change the dispensing pharmacy's responsibility for the product until it reaches the patient. Practical compliance points:
| Issue | Requirement |
|---|---|
| Counseling | An offer to counsel must still be made; delivery pharmacies typically provide written information plus a pharmacist-staffed telephone line |
| Cold chain | Refrigerated products must be transported in validated packaging that maintains 2°C to 8°C; the pharmacy owns the storage failure, not the courier |
| Delivery to the wrong person | Treat as a dispensing error: it is a reportable quality-related event under the CQI rule at 13:39-1.9 |
| Controlled substances | Delivery personnel are agents of the pharmacy; the pharmacy retains DEA recordkeeping responsibility until delivery is complete |
| Unattended drop-off | Leaving a controlled substance unattended at a door defeats the pharmacy's custody obligation and invites a diversion finding |
4. Mail and Common Carrier
Mailing prescriptions is lawful in New Jersey, and the corresponding patient-protection obligations are specific:
- Written drug information must accompany the mailed prescription.
- A toll-free telephone consultation service must be maintained, staffed by a pharmacist, available at least 6 days per week and 40 hours per week.
- That toll-free number must appear on the prescription label, so the patient who has a question at 9 p.m. has a route to a pharmacist.
Controlled substances may be sent through the U.S. Postal Service, but the outer wrapper must bear no markings indicating the contents, and the inner container must be labeled and sealed as required — the anonymity of the outer package is the security control.
Out-of-State and Non-Resident Delivery
An out-of-State pharmacy that ships prescriptions to New Jersey patients is practicing into New Jersey and is regulated accordingly. Under N.J.A.C. 13:39-4.20, the pharmacy must be registered with the Board, and must maintain at all times a valid, unexpired license, permit, or registration to operate as a pharmacy in the state where it is located. Loss of the home-state license is not merely a home-state problem; it removes the predicate for the New Jersey registration.
Internet pharmacies dispensing or delivering into New Jersey are subject to the same permit expectation — the delivery channel does not create an exemption from licensure.
Central Fill Is Not a Delivery Channel to the Patient
The centralized prescription handling rules at N.J.A.C. 13:39-4.18 draw a hard line that appears frequently on the exam. A central fill pharmacy may not deliver dispensed medications directly to patients unless it is separately licensed by the Board as a retail pharmacy, and it may not accept prescriptions directly from patients or prescribers. The finished product returns to the originating pharmacy, whose name, address, and telephone number appear on the label along with an identifier for the central fill site, and which retains responsibility for the DUR and for counseling.
What Survives the Handover
[!IMPORTANT] The single sentence to carry into the exam: delivery changes where the professional duties are performed, never whether they are performed. If a fact pattern removes the patient from the counter — mail, courier, agent, locker, or kiosk — ask what replaced the counseling offer, how the DUR was documented, whether the label carries a pharmacist-reachable number, and whether the pharmacy can show who received the medication.
Practice Scenarios
Scenario 1 — The neighbor. A neighbor arrives to collect a new prescription for gabapentin on behalf of a homebound patient. The technician bags it and is about to hand it over. Analysis: The technician may complete the physical handover, but under 13:39-7.21 the offer to counsel on a new prescription belongs to the pharmacist or a registered intern, and a technician may not solicit a counseling waiver. The correct handling is for the pharmacist to make the offer — typically by telephoning the patient or providing written information plus a direct route to the pharmacist — and to document the release.
Scenario 2 — The forgotten bag. A prescription filled on April 2 is still in will-call on April 30. Analysis: It became abandoned on April 16 under 13:39-7.16(c). Because it never left the pharmacy's exclusive custody it may go back into stock, but only if all six conditions are met — including that it not be commingled with a different lot number or expiration date and that it not be dispensed later than one year from April 2, carrying its original use-by date.
Scenario 3 — The mail-order label. An out-of-State mail-order pharmacy ships a 90-day supply of levothyroxine to a Trenton patient. The label lists the pharmacy's name and address but no telephone number, and the shipment contains only the manufacturer's insert. Analysis: Two deficiencies. The pharmacy must maintain a pharmacist-staffed toll-free consultation service available at least 6 days and 40 hours per week, with that number printed on the label, and it must supply written drug information. Separately, the pharmacy must be registered with the New Jersey Board under 13:39-4.20 and hold a current license in its home state.
Scenario 4 — The unattended porch. A courier for a New Jersey pharmacy leaves a sealed bag containing an alprazolam prescription on a porch when nobody answers the door. Analysis: The pharmacy retains custody responsibility until the controlled substance reaches the patient or the patient's agent. An unattended drop-off is a loss-of-custody event that should be handled under the pharmacy's diversion and CQI procedures, and it will not withstand scrutiny in a DEA or Board inquiry.
A New Jersey pharmacy mails maintenance prescriptions to patients throughout the state. Which combination of obligations attaches to that delivery model?
A central fill pharmacy under common ownership with a Paterson retail pharmacy proposes to ship completed prescriptions directly to the retail pharmacy's patients to save a delivery leg. Is this permissible under N.J.A.C. 13:39-4.18?
A prescription for escitalopram was filled and placed in the will-call bin on June 1. On June 25 the patient still has not picked it up. What is the medication's status, and what constrains its return to stock?